These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 2887288)
21. Arrhythmias as predictors of sudden death. Coumel P; Leclercq JF; Leenhardt A Am Heart J; 1987 Oct; 114(4 Pt 2):929-37. PubMed ID: 2889343 [TBL] [Abstract][Full Text] [Related]
22. [Arrhythmias in chronic heart failure. Prognostic significance and treatment]. Koenig A; Chauvin M; Thévenin D; Brechenmacher C Presse Med; 1991 May; 20(20):950-5. PubMed ID: 1676164 [TBL] [Abstract][Full Text] [Related]
23. Asymptomatic ventricular ectopy. To treat or not to treat? Lofgren RP; Hoppe RB Postgrad Med; 1983 Apr; 73(4):261-4, 267-71, 274. PubMed ID: 6132372 [TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. Das MK; Zipes DP J Cardiovasc Pharmacol; 2010 May; 55(5):438-49. PubMed ID: 20509177 [TBL] [Abstract][Full Text] [Related]
25. [Preventive antifibrillatory treatment of sudden cardiac death in acute myocardial infarct]. Thale J; Gülker H; Hindricks G; Haverkamp W; Pollock B; Buchwalsky R Z Kardiol; 1988; 77 Suppl 4():11-22. PubMed ID: 3062962 [TBL] [Abstract][Full Text] [Related]
26. [Secondary prevention of myocardial infarction using anti-arrhythmia agents and beta-receptor blockers]. Mösslacher H Acta Med Austriaca; 1984; 11(1):1-8. PubMed ID: 6143463 [TBL] [Abstract][Full Text] [Related]
27. Treatment and prevention of sudden cardiac death--what have we learnt from randomised clinical trials? Kam RM; Teo WS; Koh TH; Lim YL Singapore Med J; 1999 Nov; 40(11):707-10. PubMed ID: 10709412 [TBL] [Abstract][Full Text] [Related]
28. The role of antiarrhythmic drugs in prevention of sudden cardiac death. Podrid PJ Cardiovasc Clin; 1985; 15(3):265-86. PubMed ID: 2421903 [No Abstract] [Full Text] [Related]
29. A review of carvedilol arrhythmia data in clinical trials. Kowey PR J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S59-68. PubMed ID: 15965573 [TBL] [Abstract][Full Text] [Related]
30. [Anti-arrhythmia agents in the prevention of sudden cardiac death after myocardial infarct]. Cagán S; Jurkovicová O Bratisl Lek Listy; 1997; 98(7-8):413-22. PubMed ID: 9471336 [TBL] [Abstract][Full Text] [Related]
32. [Prevention of sudden death with antiarrhythmic agents after myocardial infarction]. Raviele A; Gasparini G G Ital Cardiol; 1992 Apr; 22(4):463-7. PubMed ID: 1385246 [No Abstract] [Full Text] [Related]
33. [Arrhythmic syndrome and sudden death in hypertrophic cardiomyopathy]. Storozhakov GI; Selivanov AI; Kisliak OA Ter Arkh; 1988; 60(8):137-41. PubMed ID: 2906486 [No Abstract] [Full Text] [Related]
34. Delayed and indirect effects of antiarrhythmic drugs in reducing sudden cardiac death. Malhotra S; Das MK Future Cardiol; 2011 Mar; 7(2):203-17. PubMed ID: 21453027 [TBL] [Abstract][Full Text] [Related]
36. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study]. Seipel L; Kühlkamp V Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728 [TBL] [Abstract][Full Text] [Related]
37. [Ventricular hyperkinetic arrhythmias: a current therapeutic problem. The possible greater use of beta blockers]. Iannetti M; Marchese F; Perocchio M Minerva Cardioangiol; 1992 Dec; 40(12):467-78. PubMed ID: 1363579 [TBL] [Abstract][Full Text] [Related]
38. Sudden cardiac death--an approach to management of the patient at risk. Podrid PJ; Blatt CM Herz; 1984 Apr; 9(2):65-76. PubMed ID: 6714916 [TBL] [Abstract][Full Text] [Related]